| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| « Mar | May » | |||||
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 | ||||||
April 20th, 2012 tmccoy
by: James Kapralos, Esq. Management of pressure ulcers in nursing homes require excellent clinical evaluations, history, physical examination and decision-making. Wound care and prevention must be implemented fast. Prevention and care for an ulcer must include skin checks every shift and immediate notification to a doctor for action if there is any change to the [...]
April 20th, 2012 tmccoy
by: William Dubanevich, Esq. When we look for a home, we are careful took look at locations that may be unsafe and unhealthy for our family. But no one ever thinks about living near a military base can be putting you and your loved ones in harm’s way. Military bases all over the country are [...]
April 20th, 2012 tmccoy
by: Daniel C. Burke, Esq. Many patients understand the risks they face when taking a prescription drug. Most complications that arise from drugs do not take long to surface. But what happens when someone uses a drug for years but then gets sick? Our client is a good example of how a drug can be [...]
April 20th, 2012 tmccoy
The FDA warned today against combining the blood pressure medication Tekturna (Aliskiren) with ACE inhibitors and angiotensin receptor blockers (ARBS) in patients with diabetes or kidney problems. The warning, which will be accompanied by a label change, is based on results from the terminated ALTITUDE study, which found an increased risk of adverse events in [...]
April 20th, 2012 tmccoy
by: Jonathan Macri, Esq. According to the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA), a recent epidemiological study has revealed that individuals who take proton pump inhibitors may be at a higher risk of fractures if they stay on these types of drugs for too long. In May 2010, the manufacturers of prescription PPI’s [...]
April 20th, 2012 tmccoy
by: Stephanie Herschaft, Esq. Novartis AG is updating the label on its oral multiple sclerosis drug Gilenya in order to prevent possibly deadly heart problems. The U.S. label from this point forward will now state that patients with cardiac conditions such as heart attack or stroke in the last six months should not take Gilenya. [...]
April 20th, 2012 tmccoy
by: Jay Breakstone, Esq. In an election year when everyone realizes how important big money political contributions can be, Republicans in the House pushed their unsupported HEALTH Act. The proposed legislation would force Americans who were victims of medical malpractice to limit their pain and suffering to only $250,000. If that weren’t enough of a [...]
